Used as an intermediate in Suzuki-Miyaura cross-coupling reactions for the synthesis of biologically active compounds, particularly in pharmaceutical research. Its boronate ester group enables efficient carbon-carbon bond formation, making it valuable in constructing complex heterocyclic systems found in drug candidates. Commonly applied in the development of kinase inhibitors and other targeted therapies due to the fluorinated pyrrolopyridine scaffold's favorable binding properties and metabolic stability.